4.5 Article

Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study

Related references

Note: Only part of the references are listed.
Article Respiratory System

Exercise pulmonary haemodynamics predict outcome in patients with systemic sclerosis

Adriana Stamm et al.

EUROPEAN RESPIRATORY JOURNAL (2016)

Article Critical Care Medicine

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis An Update of the 2011 Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Critical Care Medicine

Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia

Tamera J. Corte et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Article Critical Care Medicine

Advanced Echocardiography for the Critical Care Physician Part 2

Mangala Narasimhan et al.

CHEST (2014)

Article Medicine, General & Internal

Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan A Parallel, Randomized Trial

Ganesh Raghu et al.

ANNALS OF INTERNAL MEDICINE (2013)

Review Cardiac & Cardiovascular Systems

Pulmonary Hypertension in Chronic Lung Diseases

Werner Seeger et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Article Critical Care Medicine

GOLD 2011 disease severity classification in COPDGene: a prospective cohort study

MeiLan K. Han et al.

LANCET RESPIRATORY MEDICINE (2013)

Editorial Material Respiratory System

Pulmonary vascular responses to exercise: a haemodynamic observation

R. Saggar et al.

EUROPEAN RESPIRATORY JOURNAL (2012)

Article Cardiac & Cardiovascular Systems

Impact of pulmonary hemodynamics on 6-min walk test in idiopathic pulmonary fibrosis

Omar A. Minai et al.

RESPIRATORY MEDICINE (2012)

Article Critical Care Medicine

BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Respiratory System

Exercise stress echocardiography for the study of the pulmonary circulation

P. Argiento et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Article Cardiac & Cardiovascular Systems

Diagnosis and Assessment of Pulmonary Arterial Hypertension

David B. Badesch et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Respiratory System

Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease

Giuseppe Valerio et al.

Therapeutic Advances in Respiratory Disease (2009)

Article Critical Care Medicine

BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

Talmadge E. King et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Review Respiratory System

Pulmonary hypertension in interstitial lung disease

J. Behr et al.

EUROPEAN RESPIRATORY JOURNAL (2008)

Article Respiratory System

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant

A. F. Shorr et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Article Respiratory System

Safety and tolerability of bosentan in idiopathic pulmonary fibrosis:: an open label study

A. Guenther et al.

EUROPEAN RESPIRATORY JOURNAL (2007)

Article Critical Care Medicine

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

A Azuma et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Article Medicine, General & Internal

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

BR Celli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)